What is UroGen Pharma's AOCI?

UroGen Pharma (URGN) reported AOCI of $8K in Q1 2026.

How has UroGen Pharma's AOCI changed year-over-year?

UroGen Pharma's AOCI decreased by 42.9% year-over-year, from $14K to $8K.

What is the long-term trend for UroGen Pharma's AOCI?

Over 5 years (2020 to 2025), UroGen Pharma's AOCI has grown at a -41.2% compound annual growth rate (CAGR), from $271K to $19K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

UroGen Pharma URGN AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

PfizerPFE

-$7.2B+16.1%

Johnson & JohnsonJNJ

-$14.83B-26.3%

Merck & Co.MRK

-$4.06B+18.2%

ImmunityBio, Inc.IBRX

$27.45M+37.6%

Tyra Biosciences, Inc.TYRA

$107K-84.4%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's AOCI?: UroGen Pharma (URGN) reported AOCI of $8K in Q1 2026.
How has UroGen Pharma's AOCI changed year-over-year?: UroGen Pharma's AOCI decreased by 42.9% year-over-year, from $14K to $8K.
What is the long-term trend for UroGen Pharma's AOCI?: Over 5 years (2020 to 2025), UroGen Pharma's AOCI has grown at a -41.2% compound annual growth rate (CAGR), from $271K to $19K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.